4.7 Article

Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

Eric J. Chow et al.

Summary: In this study, dexrazoxane did not appear to have a negative impact on long-term mortality, event-free survival, or risk of second cancer. Additionally, patients treated with dexrazoxane had lower rates of serious cardiovascular outcomes in some aspects.

CANCER (2022)

Review Oncology

Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells

Rachel E. Nicoletto et al.

Summary: This review updates the concentration and time-dependent trends of doxorubicin (DOX) mechanisms at representative clinical concentrations, with a focus on DOX behavior in breast cancer cells. It provides insight into the mechanistic pathway(s) of DOX at levels found within patients and establishes the magnitude of effect for each mechanism.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review

Rony Abdi Syahputra et al.

Summary: Doxorubicin is a widely used anticancer drug, but its therapeutic value is hindered by dose-dependent cardiotoxicity. This review summarizes the cardioprotective effects of flavonoids against doxorubicin-induced cardiac toxicity in both in vitro and in vivo models.

MOLECULES (2022)

Review Oncology

Recent Insights into Therapy Resistance in Osteosarcoma

Zachary D. Prudowsky et al.

Summary: Osteosarcoma is the most common bone malignancy of childhood. Standard chemotherapy regimens work well for many patients, but there are minimal options for patients with progressive or resistant disease. A better understanding of therapy resistance is necessary to improve current treatments and design new strategies for future treatment options.

CANCERS (2021)

Review Chemistry, Medicinal

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics

Archana Adhikari et al.

Summary: Advancements in therapy have improved the recovery rate of cancer patients, but also increased the risk of cardiovascular complications. Chemotherapy-induced cardiotoxicity is a life-threatening consequence that limits the use of certain chemotherapy drugs in clinical practice.

PHARMACEUTICALS (2021)

Review Cardiac & Cardiovascular Systems

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications

Agata Bikiewicz et al.

Summary: Breast cancer is the most common cancer diagnosis in women, with significant progress in treatment but an increased risk of cardiovascular complications. Current recommendations suggest periodic monitoring of the cardiovascular system during treatment.

ESC HEART FAILURE (2021)

Review Medicine, Research & Experimental

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

Pushkar Singh Rawat et al.

Summary: Doxorubicin, a commonly used anti-cancer drug, exerts its activity through DNA intercalation and inhibition of topoisomerase II enzyme. However, its use is limited by its dose-dependent cardiotoxicity, which is believed to involve oxidative stress, apoptosis, and various other mechanisms. Pharmacological strategies have been explored to mitigate Doxorubicin-induced cardiotoxicity.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Biochemistry & Molecular Biology

Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review

Izabela Koss-Mikolajczyk et al.

Summary: Cardiotoxicity, a common side effect of oncological treatment, can limit the therapeutic dose of antitumor drugs and reduce the effectiveness of cancer eradication. Oxidative stress induced by chemotherapy is a major underlying cause of cardiotoxicity. Utilizing a diet rich in antioxidants from edible plants may help decrease the toxicity of antitumor drugs and lower the risk of cardiac failure.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Pharmacology & Pharmacy

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician

Ekaterina Yu Podyacheva et al.

Summary: Currently, there is an expansion in the pharmacological possibilities of treating cancer, leading to an increase in life expectancy with chemotherapy and supportive treatment. However, complications such as anthracycline-induced cardiomyopathy are a significant concern, requiring further research to understand its development mechanisms through new models.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Hydroxytyrosol Selectively Affects Non-Enzymatic Glycation in Human Insulin and Protects by AGEs Cytotoxicity

Ivana Sirangelo et al.

Summary: This study demonstrates that Hydroxytyrosol (HT) selectively inhibits protein glycation reaction and counteracts the cytotoxicity induced by advanced glycation end-products (AGEs) in human neurotypical cells, suggesting its potential as a promising molecule in protecting against neurodegenerative disorders.

ANTIOXIDANTS (2021)

Review Biochemistry & Molecular Biology

Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties

Monica Bucciantini et al.

Summary: Oxidative stress and inflammation are major causes of chronic diseases, leading to the search for new active substances without side effects. Plant-derived compounds offer potential as anti-inflammatory and antioxidant molecules, with natural products being structurally optimized by evolution for specific biological functions. Extensive studies have shown the therapeutic effects of polyphenols from extra virgin olive oil against various chronic diseases, highlighting their role in inhibiting molecular signaling pathways activated by oxidative stress.

ANTIOXIDANTS (2021)

Article Oncology

Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

A. Mecinaj et al.

Summary: The study aims to evaluate the efficacy of sacubitril/valsartan in preventing cardiac dysfunction in early breast cancer treatment. PRADA II is a randomized, placebo-controlled trial assessing changes in left ventricular function in patients receiving anthracyclines with or without trastuzumab. The results will provide valuable insights into cardioprotection during cancer therapy and may help identify patients at higher risk of cardiotoxicity.

CARDIO-ONCOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity

Allison Padegimas et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

Healthy Effects of Plant Polyphenols: Molecular Mechanisms

Manuela Leri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell Biology

Red orange and lemon extract prevents the renal toxicity induced by ochratoxin A in rats

Sara Damiano et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition

Jaewon Oh et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p

Xiaoxue Yu et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Biochemistry & Molecular Biology

Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin

Ivana Sirangelo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health

Ana Karkovic Markovic et al.

MOLECULES (2019)

Review Toxicology

Oxidative stress injury in doxorubicin-induced cardiotoxicity

Mei Songbo et al.

TOXICOLOGY LETTERS (2019)

Review Health Care Sciences & Services

Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence

Katarzyna Korzeniowska et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)

Review Oncology

Current and future therapeutic approaches for osteosarcoma

Douglas J. Harrison et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

Review Cell Biology

Adult-onset brain tumors and neurodegeneration: Are polyphenols protective?

Tiziana Squillaro et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

Monica Samuel Avila et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Pharmacology & Pharmacy

Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes

Teresa Cunha-Oliveira et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)

Review Biochemistry & Molecular Biology

Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives

Jessica Marinello et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cardiac & Cardiovascular Systems

Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 1

Hui-Ming Chang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Medicine, Research & Experimental

Polyphenols, autophagy and doxorubicin-induced cardiotoxicity

S. Shabalala et al.

LIFE SCIENCES (2017)

Review Biochemistry & Molecular Biology

Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity

Alvaro Mordente et al.

CURRENT MEDICINAL CHEMISTRY (2017)

Review Medicine, Research & Experimental

Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity

Abdelrahman Ibrahim Abushouk et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Cardiac & Cardiovascular Systems

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Massimo F. Piepoli et al.

EUROPEAN HEART JOURNAL (2016)

Review Biochemistry & Molecular Biology

Nutraceutical Properties of Olive Oil Polyphenols. An Itinerary from Cultured Cells through Animal Models to Humans

Stefania Rigacci et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Oncology

The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review

Kamal Razavi-Azarkhiavi et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2016)

Review Cell Biology

Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity

Shreesh Ojha et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Article Biochemistry & Molecular Biology

Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation

Natalia Kitsati et al.

REDOX BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts

Vane Sirangelo et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2016)

Review Cell Biology

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress

Paweorn Angsutararux et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)

Article Pharmacology & Pharmacy

Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression

Qinghua Dong et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

Article Pharmacology & Pharmacy

Sesamol prevents doxorubicin-induced oxidative damage and toxicity on H9c2 cardiomyoblasts

Pawan G. Nayak et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)

Article Cell Biology

Cellular Mechanisms Controlling Caspase Activation and Function

Amanda B. Parrish et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Review Pharmacology & Pharmacy

Anthracycline cardiotoxicity

Pierantonio Menna et al.

EXPERT OPINION ON DRUG SAFETY (2012)

Review Cardiac & Cardiovascular Systems

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Yanti Octavia et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)

Article Biochemistry & Molecular Biology

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Sui Zhang et al.

NATURE MEDICINE (2012)

Article Medicine, Research & Experimental

Functional characterization of osteosarcoma cell lines provides representative models to study the human disease

Alexander B. Mohseny et al.

LABORATORY INVESTIGATION (2011)

Review Biochemistry & Molecular Biology

Toxic proteins released from mitochondria in cell death

X Saelens et al.

ONCOGENE (2004)

Article Cardiac & Cardiovascular Systems

Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro

P Spallarossa et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)

Article Medicine, Research & Experimental

Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis

WP Tsang et al.

LIFE SCIENCES (2003)

Review Pharmacology & Pharmacy

Doxorubicin-induced cardiac mitochondrionopathy

KB Wallace

PHARMACOLOGY & TOXICOLOGY (2003)

Review Cell Biology

Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis

M Crompton

CURRENT OPINION IN CELL BIOLOGY (2000)